LMI is set for strong growth, leveraging NeuraCeq® expansion, a robust product pipeline, and stable R&D services. The company targets a $2.5B market, aiming for 20%-40% share and >$900M peak annual sales from new products.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.